On June 15, 2026, the National Institutes of Health (NIH) announced that moving forward, NICEATM will continue its important work as a division of the newly created NIH Office of Research Innovation, Validation, and Application (ORIVA). Soon, NICEATM content that you see on this webpage will be transitioned to the NIH ORIVA webpage. In the meantime, you can learn more about the new office and how it is structured.

https://ntp.niehs.nih.gov/go/iccvamforum-2026

ICCVAM Public Forum: July 2026

Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): advancing alternatives to animal testing

July 29-30, 2026

NIH Neuroscience Center Building, 6001 Executive Blvd., Rockville, MD

Register to attend in person by Wednesday, July 22

Register to submit a public comment by Wednesday, July 22

Register to view the webcast: may be done up through the end of the meeting

Agenda (July 13 draft - subject to change)

ICCVAM’s goals include promotion of national and international partnerships between governmental and nongovernmental groups, including academia, industry, advocacy groups, and other key stakeholders. To foster these partnerships ICCVAM holds annual public forums to share information and facilitate direct communication of ideas and suggestions from stakeholders.

Representatives of ICCVAM member agencies will describe their agencies' activities both to advance new approaches to safety testing of chemicals and medical products and to reduce the amount of testing required. Participants will be able to ask clarifying or follow-up questions of the ICCVAM members about their presentations during the meeting. Stakeholders will also be able to present public statements on ICCVAM activities. Registration is required to present public statements; attendees do not need to register in advance to be able to ask presenters questions during the meeting.

ICCVAM also welcomes written public statements from interested stakeholders. Those who wish to submit a written public statement should email NICEATM by Friday, July 24, with their statement attached as either a Word or PDF document. Written statements submitted will be posted on this webpage, so no personal, confidential, or sensitive information should be included in the statement. 

NTP Guidelines for Public Comments